期刊文献+

植入依托孕烯埋植剂12个月临床效果观察 被引量:13

Observation of clinical effect of etonogestrel implant in 12 mouths
下载PDF
导出
摘要 目的:评价依托孕烯埋植剂避孕的有效性、阴道出血模式、副作用、安全性及可接受性;方法:选择采用依托孕烯埋植剂避孕的妇女150例为研究对象,月经期或人工流产术后植入埋植剂,术后1、3、6、12个月随访,记录其临床症状、副作用、阴道出血情况及取出原因。结果:150例妇女植入依托孕烯埋植剂12个月内无一例妊娠。出血模式主要表现为出血类型的异常,即闭经(32.4%)、出血稀发(23.1%)、出血延长(10.2%)、出血频发(5.6%)。除出血改变外,其他主要表现为体重增加、痤疮、乳房胀痛、卵巢囊肿等。埋植剂续用率为72.0/百妇女年。结论:依托孕烯埋植剂避孕效果好,无重大不良反应发生,安全性好。出血模式的改变和体重增加是其主要副作用,也是影响续用率的主要原因。 Objective:To estimate the contraceptive efficacy,bleeding patterns,side effects,safety and acceptability of the etonogestrel implant.Methods:Form May to December 2013,women who requirement of contraception at family planning in Women's Hospital School of Medicine Zhejiang University,150 healthy women received the etonogestrel implants insertion immediately postabortion or menstrual placement.At 1,3,6,12 months follow up,a questionnaire was used to investigate the clinical symptoms,bleeding patterns,side effects,satisfaction,and the reasons for discontinuation of the included patients.Results:Pregnancy rate was 0 in the 150 patients at 12 mouths follow up.The bleeding patterns were abnormal uterine bleeding,which included amenorrhoea(32.4%),infrequent(23.1%),frequent(10.2%),and/or prolonged bleeding(5.6%).Other reported side effects included weight gain,acne,breast tenderness and ovarian cyst.The continuation rate at the end of 12 months was 72.0/ every hundred women years.Conclusion:Etonogestrel subdermal contraceptive implant has high efficacy with good safety and hasn't heavy side effects.The bleeding patterns and weight gain are not only the major side effects,but also are the main reasons for discontinuation.
出处 《中国计划生育学杂志》 2016年第1期28-32,共5页 Chinese Journal of Family Planning
关键词 依托孕烯埋植剂 阴道出血模式 副作用 安全性 续用率 Etonogestrel Implant Bleeding Pattern Side effects Safety Continuation rate
  • 相关文献

参考文献14

  • 1World Health Organization. Facts about once-a-month inject- able contraceptives: memorandum {rom a WHO meeting[J]. Bull WHO 1993,71(6) :677-689.
  • 2Tietze C,lewit S. Recommended procedures for the statiatical evaluation of intrauterine contraception. Stud Fam Plan 1973 4:35.
  • 3WHO.WHO避孕方法选用的医学标准[M].第4版.北京:中国人口出版社,2011:100-112.
  • 4Graesslin O, Korver T. The contraceptive efficacy of Impl- anon: a review of clinical trials and marketing experience [J]. Eur J Contracept Reprod Health Care, 2008,13 ( Suppl 1 ) : 4- 12.
  • 5Makarainen L, Van BA, Tuomivaara L et al. Ovarian function during the use of. a. single, contraceptive, implant: Implanon. compared.with.Norplant[J].Fertil, 1998,69 (4) :714-721.
  • 6姚晓英,杜明昆.皮下埋植剂Implanon和Norplant的临床对比性研究[J].中华妇产科杂志,2003,38(7):419-422. 被引量:7
  • 7Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of Implanon on menstrual bleeding.patterns.[J].Eur J. Contracept.Report.Health.Care, 2008,13(Suppl 1) : 13-28.
  • 8Zheng SR, Zheng HM, Qian SZ, et al. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a sixcapsule (Norplant) hormonal contraceptive implant [ J]. Contraception, 1999,60 ( 1 ) : 1-8.
  • 9Funk S,Miller MM,Mishell DR Jr,et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel [J]. Contraception, 2005,71 (5) : 319-326.
  • 10Vickery Z, Madden T, Zhao Q, et al. Weight change at 12 months in users of three progestin -only contraceptive methods [J]. Contraception, 2013,88 (4) : 503.

共引文献6

同被引文献68

引证文献13

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部